The associations of oxaliplatin-induced peripheral neuropathy, sociodemographic characteristics, and clinical characteristics with time to fall in older adults with colorectal cancer

被引:2
|
作者
Hines, Robert B. [1 ]
Schoborg, Christopher [2 ]
Sumner, Timothy [2 ]
Thiesfeldt, Dana-Leigh [3 ]
Zhang, Shunpu [2 ]
机构
[1] Univ Cent Florida, Coll Med, Dept Populat Hlth Sci, 900 Lake NonaBlvd, Orlando, FL 32827 USA
[2] Univ Cent Florida, Coll Sci, Dept Stat & Data Sci, Orlando, FL 32827 USA
[3] Univ Cent Florida, Coll Med, Dept Med Educ, Orlando, FL 32827 USA
关键词
colorectal cancer; chemotherapy-induced peripheral neuropathy; oxaliplatin; falls; QUALITY-OF-LIFE; RISK-FACTORS; ADJUVANT TREATMENT; CHEMOTHERAPY; HEALTH; INJURIES; CIRRHOSIS; FRAILTY; PEOPLE; CLAIMS;
D O I
10.1093/aje/kwae067
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Our purpose was to investigate the associations between falls and oxaliplatin-induced peripheral neuropathy (OIPN), sociodemographic characteristics, and clinical characteristics of older patients with colorectal cancer. The study population consisted of older adults diagnosed with colorectal cancer whose data were obtained from the Surveillance, Epidemiology, and End Results database combined with Medicare claims. We defined OIPN using specific (OIPN 1) and broader (OIPN 2) definitions of OIPN, based on diagnosis codes. Extensions of the Cox regression model to accommodate repeated events were used to obtain overall hazard ratios (HRs) with 95% CIs and the cumulative hazard of fall. The unadjusted risk of fall for colorectal cancer survivors with versus without OIPN 1 at 36 months of follow-up was 19.6% versus 14.3%, respectively. The association of OIPN with time to fall was moderate (for OIPN 1, HR = 1.37; 95% CI, 1.04-1.79) to small (for OIPN 2, HR = 1.24; 95% CI, 1.01-1.53). Memantine, opioids, cannabinoids, prior history of fall, female sex, advanced age and disease stage, chronic liver disease, diabetes, and chronic obstructive pulmonary disease all increased the hazard rate of falling. Incorporating fall prevention in cancer care is essential to minimize morbidity and mortality of this serious event in older survivors of colorectal cancer.
引用
收藏
页码:1271 / 1280
页数:10
相关论文
共 50 条
  • [21] Impact of oxaliplatin-induced neuropathy in patients with colorectal cancer: a prospective evaluation at a single institution
    Dault, R.
    Rousseau, M. P.
    Beaudoin, A.
    Frenette, M. A.
    Lemay, F.
    Beauchesne, M. F.
    CURRENT ONCOLOGY, 2016, 23 (01) : E65 - E69
  • [22] Efficacy and safety of electroacupuncture for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: a single-blinded, randomized, sham-controlled trial
    Chan, Kaiyin
    Lui, Louisa
    Lam, Yukting
    Yu, Kaling
    Lau, Kwongwai
    Lai, Manchi
    Lau, Waiwai
    Tai, Lokyin
    Mak, Chunkin
    Bian, Zhaoxing
    Zhong, Linda L. D.
    ACUPUNCTURE IN MEDICINE, 2023, 41 (05) : 268 - 283
  • [23] Role of metformin in oxaliplatin-induced peripheral neuropathy in patients with stage III colorectal cancer: randomized, controlled study
    El-fatatry, Basma Mahrous
    Ibrahim, Osama Mohamed
    Hussien, Fatma Zakaria
    Mostafa, Tarek Mohamed
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2018, 33 (12) : 1675 - 1683
  • [24] Role of metformin in oxaliplatin-induced peripheral neuropathy in patients with stage III colorectal cancer: randomized, controlled study
    Basma Mahrous El-fatatry
    Osama Mohamed Ibrahim
    Fatma Zakaria Hussien
    Tarek Mohamed Mostafa
    International Journal of Colorectal Disease, 2018, 33 : 1675 - 1683
  • [25] Oxaliplatin-induced peripheral neuropathy’s effects on health-related quality of life of colorectal cancer survivors
    Cindy Tofthagen
    Kristine A. Donovan
    Mary Ann Morgan
    David Shibata
    Yating Yeh
    Supportive Care in Cancer, 2013, 21 : 3307 - 3313
  • [26] Late effects of oxaliplatin-induced peripheral neuropathy (LEON)-cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years
    Padman, Sunita
    Lee, Jaein
    Kumar, Rajiv
    Slee, Mark
    Hakendorf, Paul
    Richards, Alison
    Koczwara, Bogda
    Kichenadasse, Ganessan
    Sukumaran, Shawgi
    Roy, Amitesh
    Vatandoust, Sina
    Karapetis, Christos S.
    SUPPORTIVE CARE IN CANCER, 2015, 23 (03) : 861 - 869
  • [27] Study protocol: fish oil supplement in prevention of oxaliplatin-induced peripheral neuropathy in adjuvant colorectal cancer patients – a randomized controlled trial. (OxaNeuro)
    Nina Lykkegaard Gehr
    Páll Karlsson
    Signe Timm
    Signe Christensen
    Christian Andreas Hvid
    Jana Peric
    Torben Frøstrup Hansen
    Lotte Lauritzen
    Nanna Brix Finnerup
    Lise Ventzel
    BMC Cancer, 24
  • [28] Oxaliplatin rechallenge in metastatic colorectal cancer patients with clinically significant oxaliplatin-induced peripheral neurotoxicity
    Argyriou, Andreas A.
    Kalofonou, Foteini
    Litsardopoulos, Pantelis
    Anastopoulou, Garifallia G.
    Kalofonos, Haralabos P.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2021, 26 (01) : 43 - 48
  • [29] Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
    Kawashiri, Takehiro
    Mine, Keisuke
    Kobayashi, Daisuke
    Inoue, Mizuki
    Ushio, Soichiro
    Uchida, Mayako
    Egashira, Nobuaki
    Shimazoe, Takao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (03) : 1 - 25
  • [30] Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment
    Lumei Kang
    Yuyang Tian
    Shilin Xu
    Hongping Chen
    Journal of Neurology, 2021, 268 : 3269 - 3282